The STAR trial protocol: a randomised multi-stage phase II/III study of Sunitinib comparing temporary cessation with allowing continuation, at the time of maximal radiological response, in the first-line treatment of locally advanced/metastatic renal cancer. uri icon

authors

  • Collinson, Fiona J
  • Wah, T
  • Selby, Peter J
  • Hewison, Jenny
  • Brown, Julia
  • Brown, Janet
  • Gregory, Walter M
  • McCabe, Chris
  • Howard, Helen
  • Lowe, Catherine
  • Potrata, DrBarbara
  • Tubeuf, Sandy
  • Hanlon, Pat
  • McParland, Lucy

publication date

  • January 1, 2012